Biolase, Inc. · OTC:BIOLQ
Biolase — Investor Presentation (October 2020)
21 slides from Biolase's investor presentation, Oct 27, 2020
Slide 1: Investor Presentation
Exhibit 99.1 INVESTOR PRESENTATION NASDAQ CM: BIOL October 2020Exhibit 99.1 INVESTOR PRESENTATION NASDAQ CM: BIOL October 2020
Slide 2: Safe Harbor Statement
Safe Harbor Statement Statements made in this presentation and during discussions with BIOLASE representative’s that refer to BIOLASE’s estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements its representatives make concerning BIOL
Slide 3: BIOLASE Overview
BIOLASE Overview Complete line of products for Leading global provider of dental Sold over 40,000 laser systems into general dentists, specialists and lasers for cosmetic, restorative and 80 countries to date dental practitioners surgical applications Experienced management team Established revenue
Slide 4: Full-Spectrum of Laser Systems and Consumables
Full-Spectrum of Laser Systems and Consumables Epic Pro™ Waterlase Express™ • Powerful and capable diode dental laser ever • Speed, comfort, and precision cutting • Small, easy to operate and cost-effective Waterlase • Leverages IPG Medical technology • Vivid HD tablet user interface • Exclusive pro
Slide 5: Lasers Widely Used in Medicine
Lasers Widely Used in Medicine üMinimally invasive LASIK üLess bleeding/trauma üFaster healing üEnhanced precision üMore patient-friendly experience Training is the key driver of adoption – Waterlase Mentoring Experience (WME) Program 5Lasers Widely Used in Medicine üMinimally invasive LASIK üLess b
Slide 6: COVID-19: CDC/ADA provides new guidance
COVID-19 CDC/ADA provides new guidance is well positioned to benefit!COVID-19 CDC/ADA provides new guidance is well positioned to benefit!
Slide 7: Aerosol Production and Contamination Risk
Aerosol Production and Contamination Risk The risk of cross contamination in the dental office is HIGH due to aerosol production 50ml/min 8ml/min Dental Drill Waterlase Dentistry 7Aerosol Production and Contamination Risk The risk of cross contamination in the dental office is HIGH due to aerosol pr
Slide 8: Epic Hygiene – The right product at the right time!
Epic Hygiene – The right product at the right time! Sales Aid Practice Guidebook 8Epic Hygiene – The right product at the right time! Sales Aid Practice Guidebook 8
Slide 9: Webinar series featuring top names in dentistry
10,000+ Attendees: 3,000+ Follow-Ups Webinar series featuring the top names in dentistry, including: Dr. Low: Perio & Implantitis 2,500+ attendees 900+ follow-up requests Paula Quinn, RDH: Hygiene 1,000+ attendees 250+ follow-up requests Theresa Duncan: Reimbursement 700+ attendees Dr. Christensen:
Slide 10: BIOLASE Partnership Program (BPP)
BIOLASE Partnership Program (BPP) ü Enables customers to generate revenue without any cash outflow in 2020 ü Puts money in the customers pocket now ü Write off the entire amount of purchase in 2020 without making any payments until 2021 ü When offices open, it will be critical to get patients to com
Slide 11: Targeting the right segments for growth
Is targeting the right segments for growthIs targeting the right segments for growth
Slide 12: A Significant Growth Opportunity
A Significant Growth Opportunity An estimated 60 Million people in U.S. alone have gum disease and increased health risk due to the connection between oral and systemic health Under-diagnosed, Under-treated, Peri-implantitis Stats on #s going to dentist Under-managed • Over 2.7 million implants plac
Slide 13: NEW! Just Released. Minimally invasive perio protocols
NEW! Just Released. Minimally invasive perio protocols for the Complete Office. Waterlase Mentoring Experience Landmark Study FDA Clearance 12/19 LBR Clearance 03/20 55% Sales Closure McGuire Release 7/2020 13NEW! Just Released. Minimally invasive perio protocols for the Complete Office. Waterlase M
Slide 14: WME for the General Dentist
WME for the General Dentist 14WME for the General Dentist 14
Slide 15: Real Perio Results… Backed by Real Research
Real Perio Results… Backed by Real Research New Standard of Care Protocols for Perio Excellence • The minimally invasive Waterlase REPAIR™ protocols achieve superior patient reported outcomes (less pain, swelling, bruising) and faster procedure times — with equivalent clinical results to the latest
Slide 16: Opportunity Zone: Endodontics
Opportunity Zone ENDODONTICSOpportunity Zone ENDODONTICS
Slide 17: GentleWave by Sonendo vs Waterlase Endodontics
® GentleWave by Sonendo Waterlase Endodontics Solving the Irrigation Problem- A Clean Canal Traditional irrigation typically does not produce the webbing between the main canals FDA clearance in 2014 u Slower procedure u Less versatile “The postop cone beams u Higher Capital cost are phenomenal” u D
Slide 18: Key Drivers of Adoption
Key Drivers of Adoption “LASIK” surgery provides a good model for the potential adoption of Waterlase Education Corporate Adoption LASIK Clinical Support FDA Clearance 40+ Million Procedures (2) WW Waterlase In-Progress In-Progress In-Progress Waterlase Mentoring (1) McGuire Study Dental Service Org
Slide 19: Competitive Landscape
Competitive Landscape Dental Lasers Sold 1 All Tissue Lasers Global Share Diode Lasers Global Share Global Share Elexxion AG All Tissue Sirona 6% 4% DenMat 3% Deka 5% Others 4% Deka 7% 13% ARC Laser All others J.Morita 9% 7% 22% Diodes Syneron 11% Biolase GIGAA 7% 87% 52% Biolase 24% Kavo 8% Fotona
Slide 20: Current All Tissue Laser Market Penetration
Current All Tissue Laser Market Penetration BIOLASE Opportunity 7% Every 1% increase in adoption in US = over $50M in revenue for BIOLASE Strategy to expand and grow the US Pie: 1,300 DSOs, 16% of ~5K Endodontists 200K Hygienists, ~5K Periodontists ~150K GPs Mkt, 15% CAGR 35% Mkt Adoption • Key Infl
Slide 21: Thank You
THANK YOU For further information, please contact: John Beaver, EVP, CFO & COO, BIOLASE, Inc. Email: jbeaver@biolase.com Phone: 949-226-8124 NASDAQ CM: BIOLTHANK YOU For further information, please contact: John Beaver, EVP, CFO & COO, BIOLASE, Inc. Email: jbeaver@biolase.com Phone: 949-226-8124 NAS